NeuroSense Therapeutics (NRSN) Ownership - Who owns NeuroSense Therapeutics?
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NRSN showed earnings on August 01, 2025. You can read more about the earnings report here.